|
ANGEL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.113880E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.880420E-03 |
| Normal-vs-Stage2 |
9.740200E-01 |
| Normal-vs-Stage3 |
3.888600E-01 |
| Normal-vs-Stage4 |
9.486600E-01 |
| Stage1-vs-Stage2 |
2.853400E-01 |
| Stage1-vs-Stage3 |
4.110000E-01 |
| Stage1-vs-Stage4 |
5.241200E-01 |
| Stage2-vs-Stage3 |
5.832000E-01 |
| Stage2-vs-Stage4 |
9.636200E-01 |
| Stage3-vs-Stage4 |
7.191200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.263890E-02 |
| Normal-vs-AfricanAmerican |
1.975980E-01 |
| Normal-vs-Asian |
3.119600E-03 |
| Caucasian-vs-AfricanAmerican |
6.744400E-01 |
| Caucasian-vs-Asian |
1.444830E-01 |
| AfricanAmerican-vs-Asian |
3.834200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.939200E-03 |
| Normal-vs-Female |
5.927200E-01 |
| Male-vs-Female |
9.668300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.416200E-01 |
| Normal-vs-Extreme_Weight |
1.060270E-03 |
| Normal-vs-Obese |
3.514600E-01 |
| Normal-vs-Extreme_Obese |
1.075600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.981400E-01 |
| Normal_Weight-vs-Obese |
9.916200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.447400E-01 |
| Extreme_Weight-vs-Obese |
1.084770E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.123600E-01 |
| Obese-vs-Extreme_Obese |
3.995800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.119600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.563800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.517870E-03 |
| Normal-vs-Age(81-100Yrs) |
3.983000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.761400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.212200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.083000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.908200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.111940E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.181440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.864200E-02 |
| Normal-VS-Type2 PRCC |
9.059700E-03 |
| Normal-VS-KIRP CIMP |
6.270000E-01 |
| Normal-VS-Unclassified PRCC |
4.670200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.540440E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.804200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.620600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.956000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.552800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.810000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.766600E-04 |
| Normal-vs-N1 |
3.949400E-01 |
| Normal-vs-N2 |
5.222000E-04 |
| N0-vs-N1 |
4.728200E-02 |
| N0-vs-N2 |
3.668200E-01 |
| N1-vs-N2 |
1.231840E-02 |
|
|
